RTX (RTX) has received notice of an unsolicited “mini-tender” offer made by Tutanota to RTX shareholders to purchase up to 500,000 shares of RTX common stock at a purchase price of $130.00 per share. This offer is for shares representing less than 0.04% of the outstanding shares of RTX common stock. This offer price is approximately 24.02% below the closing price of RTX common stock on December 5, 2025 ($171.10), the last trading day before the date of the offer, and is approximately 31.72% below the closing price of RTX common stock on January 6, 2026 ($190.40), the day prior to this release. The offer price of $130.00 per share is conditioned on, among other things, the closing price per share of RTX common stock exceeding $130.00 per share on the last trading day before the offer expires. This means that unless this condition is waived by Tutanota, RTX shareholders who tender their shares in the offer will sell their shares at a below-market price. RTX recommends that shareholders do not tender their shares in response to Tutanota’s offer because the offer is at a price below the market value for shares of RTX common stock and is subject to numerous additional conditions including Tutanota’s ability to obtain financing. RTX shareholders who have already tendered their shares are advised they may withdraw them by following the procedures for withdrawal described in the Tutanota offer documents prior to the expiration of the offer, which is currently scheduled for 5:00 p.m. EST on January 12, 2026, unless extended or earlier terminated. RTX does not endorse Tutanota’s unsolicited mini-tender offer and is not affiliated or associated in any way with Tutanota, its mini-tender offer, or the offer documentation.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RTX:
- Raytheon Technologies put volume heavy and directionally bearish
- RTX price target raised to $189 from $185 at Bernstein
- RTX business awarded $438M FAA contract
- RTX downgraded to Neutral from Buy at UBS
- Trump Trade: 350 drugs to see price raises despite President’s pressure
